Navigate this market better. Subscribe for FREE stock alerts and information.

Sunday, November 16, 2014

Allergan, Actavis near deal; may be announced as early as Monday, (NYSE: ACT), (NYSE: AGN), (NYSE: VRX), (TSE: VRX.TO)

Allergan Inc is near a deal to merge with Actavis Plc, with an agreement to be announced as soon as Monday, according to a person familiar with the matter.Actavis is likely to pay Allergan between $210 and $220 per share, according to the source.Actavis and Allergan declined to comment.Allergan is trying to fend off a hostile takeover by Canadian drugmaker Valeant Pharmaceuticals International Inc , which has offered about $54 billion in cash and stock for the company, but has said it was prepared to raise the figure to $200 per share.

Shares of ACT traded higher by 0.89% or $2.14/share to $243.77. In the past year, the shares have traded as low as $156.40 and as high as $254.41. On average, 2179940 shares of ACT exchange hands on a given day and today's volume is recorded at 1836539.

Allergan, Inc. is a multi-specialty health care Company focused on developing and commercializing pharmaceuticals, biologics, medical devices and over-the-counter products. Shares of AGN traded higher by 1.24% or $2.44/share to $198.65. In the past year, the shares have traded as low as $94.98 and as high as $200.99. On average, 2296180 shares of AGN exchange hands on a given day and today's volume is recorded at 1430786.

Valeant Pharmaceuticals International, Inc., formerly Biovail Corporation, is a multinational, specialty pharmaceutical company that develops, manufactures and markets a range of pharmaceutical products. Shares of VRX traded higher by 1.75% or $2.31/share to $134.21. In the past year, the shares have traded as low as $105.17 and as high as $153.10. On average, 2526030 shares of VRX exchange hands on a given day and today's volume is recorded at 2117625.

Valeant Pharmaceuticals International, Inc., formerly Biovail Corporation, is a multinational, specialty pharmaceutical company that develops, manufactures and markets a range of pharmaceutical products. Shares of VRX traded higher by 0.88% or $1.32/share to $151.47. In the past year, the shares have traded as low as $110.26 and as high as $170.45. On average, 468460 shares of VRX.TO exchange hands on a given day and today's volume is recorded at 359439.



Source